Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 
HomeAll newsMost read newsBusiness Leaders Biography 
Portrait de Matthew W. Onaitis
Age : 46
Public asset : 408,320 USD
Linked companies : Cidara Therapeutics Inc
Summary 
Mr. Matthew W. Onaitis is CFO, Secretary & General Counsel at Cidara Therapeutics, Inc.

He is on the Board of Directors at Snp Bio, Inc.

Mr. Onaitis was previously employed as Secretary & General Counsel by Ignyta, Inc., Secretary & General Counsel by Trius Therapeutics, Inc., Secretary, Senior Vice President & General Counsel by Somaxon Pharmaceuticals, Inc., an Associate General Counsel by Biogen Idec, Inc., and a Director-Legal Affairs by Elan Corp. Plc.

He received his undergraduate degree from Carnegie Mellon University and a graduate degree from Stanford Law School.


Current positions of Matthew W. Onaitis 
NameTitle Since
Cidara Therapeutics Inc
(Biotechnology & Medical Research)
CFO, Secretary & General Counsel 2016
Snp Bio, Inc. Director -


Holdings of Matthew W. Onaitis 
NameEquities%Valuation
Ignyta Inc (RXDX)
Biotechnology & Medical Research
46,4000.11%408,320 USD


Matthew W. Onaitis: Personal Network 


Most Read News 
03/18DJTIM COOK : Apple CEO Tim Cook Defends Globalization in China Speech
03/17 FERDINAND PIËCH : Former Volkswagen chairman Piech in talks to sell Porsche SE stake
03/16DJJACK MA : Trump Is a Management Challenge for Overseas Business Leaders
03/16 JEN-HSUN HUANG : Car industry players diverge on timescale for self-driving cars
03/21 CHARLES SCHWAB : Goldman building robo-adviser to give investment advice to the masses
03/20 CHARLES SCHWAB : Goldman building robo-adviser to give investment advice to the masses
03/18DJCLAUDIO DESCALZI : Italy Nominates Eni CEO Descalzi for Second Term
03/17 WARREN BUFFETT : Buffett's pay rises; Berkshire urges rejection of shareholder proposals
03/20DJMARISSA MAYER : Top Company News of the Day
03/18DJMARISSA MAYER : Top Company News of the Day
More news


© 2017 People and Ownership :   
Advertisement
Matthew W. Onaitis : Connections 
The United States Pharmacopeia
Vir Biotechnology, Inc.
Vineyard Sound Advisors LLC
Novira Therapeutics, Inc.
Perfinity Biosciences, Inc.
Rennovia, Inc.
Biomedical Sciences Careers Program, Inc.
Kinestral Technologies, Inc.
Optimer Pharmaceuticals, Inc.
Villages of Indiana



Popular Business Leaders 
William Ackman Alain Afflelou Bernard Arnault Max Azria Mary Barra Lloyd Blankfein Yannick Bolloré Warren Buffett Jean-paul Clozel Gary Cohn Tim Cook Leonardo Del Vecchio Michael Dell Jamie Dimon Klaus Engel Bill Gates Carlos Ghosn David Henry Jen-hsun Huang Carl Icahn Anshu Jain Isabelle Kocher Maurice Lévy Jack Ma Sergio Marchionne Marissa Mayer Laurent Mignon Lakshmi Mittal Luka Mucic James Murdoch Elon Musk Ferdinand Piëch Patrick Pouyanné Sumner Redstone Alexandre Ricard Wilbur Ross Charles Schwab Carlos Slim George Soros Rupert Stadler Bernard Tapie Ratan Tata François Villeroy De Galhau Axel Weber Thomas Wilson Martin Winterkorn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders